SCHEDULE 13D/A

KalVista Pharmaceuticals Inc

Common Stock, $0.001 par value per share · CUSIP: 483497103

Event date: 2025-11-01

Reporting persons may disclose overlapping interests. Their amounts are shown individually and are not added into a filing total.

Filing-level shares

Unavailable

Percent of class

Unavailable

• Frazier Life Sciences Public Fund, L.P.Reported CIK 0001863769

  Shares: 3,466,521.00 · Class: 6.9%

• FHMLSP, L.P.Reported CIK 0001879466

  Shares: 3,466,521.00 · Class: 6.9%

• FHMLSP, L.L.C.Reported CIK 0001879465

  Shares: 3,466,521.00 · Class: 6.9%

• Frazier Life Sciences X, L.P.Reported CIK 0001790879

  Shares: 1,160,700.00 · Class: 2.3%

• FHMLS X, L.P.Reported CIK 0001790880

  Shares: 1,160,700.00 · Class: 2.3%

• FHMLS X, L.L.C.Reported CIK 0001790811

  Shares: 1,160,700.00 · Class: 2.3%

• Frazier Life Sciences XI, L.P.Reported CIK 0001911592

  Shares: 394,847.00 · Class: 0.8%

• FHMLS XI, L.P.Reported CIK 0001911580

  Shares: 394,847.00 · Class: 0.8%

• FHMLS XI, L.L.C.Reported CIK 0001911623

  Shares: 394,847.00 · Class: 0.8%

• James N. TopperReported CIK 0001341382

  Shares: 1,160,700.00 · Class: 2.3%

• Patrick J. HeronReported CIK 0001365617

  Shares: 1,160,700.00 · Class: 2.3%

Amounts are as disclosed in this filing. Schedule type alone does not establish investment intent.